Single priming and booster dose of ten-valent and 13-valent pneumococcal conjugate vaccines and Streptococcus pneumoniae colonisation in children in South Africa: a single-centre, open-label, randomised trial-Reference-Cited by-同舟云学术

Single priming and booster dose of ten-valent and 13-valent pneumococcal conjugate vaccines and Streptococcus pneumoniae colonisation in children in South Africa: a single-centre, open-label, randomised trial

Published:2023-05 Issue:5 Volume:7 Page:326-335
ISSN:2352-4642
Container-title:The Lancet Child & Adolescent Health
language:en
Short-container-title:The Lancet Child & Adolescent Health

Author:

Olwagen Courtney P,Izu Alane,Mutsaerts Eleonora A M L,Jose Lisa,Koen Anthonet,Downs Sarah L,Van Der Merwe Lara,Laubscher Matt,Nana Amit J,Moultrie Andrew,Cutland Clare L,Dorfman Jeffrey R,Madhi Shabir A

Funder

University of the Witwatersrand, Johannesburg

National Research Foundation

Bill and Melinda Gates Foundation

Publisher

Elsevier BV

Subject

Developmental and Educational Psychology,Pediatrics, Perinatology and Child Health

Reference23 articles.

1. Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on prevention of pneumonia;Loo;Pediatr Infect Dis J,2014

2. Effectiveness of pneumococcal conjugate vaccine against presumed bacterial pneumonia hospitalisation in HIV-uninfected South African children: a case-control study;Madhi;Thorax,2015

3. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine;Pilishvili;J Infect Dis,2010